The government of Argentina said this Sunday that it has signed a confidentiality agreement with Cuba with a view to an eventual acquisition of COVID-19 vaccines if the candidates are able to successfully complete the stages of clinical trials and indicated that, in addition, he wants to collaborate with Cuba in its production.
The confidentiality agreement was signed between the drug regulatory bodies of both countries, said at a press conference the Argentine Minister of Health, Carla Vizzotti, after returning from Havana, where this Saturday she met with the president of Cuba, Miguel Díaz-Canel.
Vizzotti noted that of the five candidate vaccines for Cuba, three -Abdala, Sovereign02 and Soberana Plus – are “advanced”, with phase 3 underway, with some 40,000 people participating in each of those trials.
He stressed that in the next few days Cuba will have the “first cut” of data for the “interim analysis” of the phase 3 clinical trials of the Abdala vaccine, which requires three doses, and the Sovereign, with two doses of Soberana02 and a booster of Soberana Plus.
“There is not only the possibility of acquiring doses of these candidate vaccines that are already in a fairly advanced stage, but also that Argentina can collaborate and cooperate in the production process so that production can be scaled up as soon as possible,” said Cecilia. Nicolini, a presidential adviser who traveled to Cuba with Vizzotti.
MORE ARRIVAL OF OTHER VACCINES
Argentina, with a population of 45 million inhabitants and that since April has suffered a strong growth in cases of COVID-19So far, it has received 15 million 483 400 doses of vaccines from various providers.
This Monday, 2,150,000 doses will arrive from the bilateral supply agreement signed with AstraZeneca. In addition, the delivery by that laboratory of 900,000 doses that should have arrived in May is pending, while the quota of this contract corresponding to June, of 3.5 million doses, should begin to arrive as of June 14 .
Additionally, Argentina awaits the arrival this week of a new batch of the Russian vaccine Sputnik V. Vizzotti said that a new supply contract is also being worked on with the Chinese laboratory Sinopharm, which informed Argentina that it has 2 million doses available in June and 4 million in July.
On the other hand, the minister confirmed that Argentina reached an agreement with the Chinese laboratory CanSino and hopes to complete “the last steps” for the signing of a contract.
“Vital Space”: In Canada, vaccination with Pfizer was approved for minors from 12 years of age. Adolescents are huge contagious compared to younger children, which is why this measure has been taken. Dr. Elmer Huerta explains to us the importance of vaccinating adolescents when the time comes in Peru.
Newsletter All about the coronavirus
COVID-19 has put everyone on alert. Subscribe to our newsletter All about the coronavirus, where you will find the most relevant daily data in the country and the world on the progress of the virus and the fight against its spread.